Key Takeaways
- Sector: Business Services, Consumer, Healthcare Healthtech & Medtech, Industrials.
- Geography: United Kingdom.
Analysis
IK Partners’ swift €2 billion close echoes broader trends in Europe’s private equity fundraising rebound. KPS Capital Partners held a combined $7 billion in Special Situations and Mid‑Cap strategies in 2024, reflecting scale and specialization as differentiators.
On the growth capital front, the UK-based Business Growth Fund (BGF) has invested over £2.3 billion between 2020 and 2024 and plans to allocate more than £3 billion through 2030 to support small‑ and mid‑sized firms, reflecting a broader push into lower-middle‑market equity.
Industry reports from Bain and McKinsey highlight how private equity fundraising is recovering in 2025 as LPs seek differentiated managers with strong track records. Bain notes scale and specialization among fundraisers as key advantages, while McKinsey observes rising interest in continuation and evergreen funds amid tight liquidity conditions.
Key limited partners in IK Small Cap IV include the Illinois Municipal Retirement Fund (IMRF), which committed $58 million in February 2025; the Minnesota State Board of Investment, with a $125 million allocation dated November, 2024; and Pantheon International PLC (PIP), which invested $17 million also on November, 2024. These commitments reflect strong institutional support from both U.S. pension funds and global private equity investors.